首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Chromogranin A can act as a reversible processing enzyme inhibitor. Evidence from the inhibition of the IRCM-serine protease 1 cleavage of pro-enkephalin and ACTH at pairs of basic amino acids
Authors:N G Seidah  G N Hendy  J Hamelin  J Paquin  C Lazure  K M Metters  J Rossier  M Chrétien
Institution:1. Laboratories of Biochemical and Molecular Neuroendocrinology, Clinical Research Institute of Montreal (Affiliated with the University of Montreal), 110 Pine Avenue West, Montreal, Quebec H2W 1R7, Canada;2. Departments of Medicine, Royal Victoria Hospital and McGill University, Montreal, Quebec H3A 1A1, Canada;3. Laboratoire de Physiologie Nerveuse, CNRS, 91190 Gif-sur-Yvette, France
Abstract:Bovine parathyroid chromogranin A inhibits the cleavage of Z-Ala-Lys-Arg-AMC by either trypsin or IRCM-serine protease 1 (IRCM-SP1), a putative novel processing enzyme originally isolated from porcine pituitary anterior and neurointermediate lobes. On larger substrates, chromogranin A is a reversible competitive inhibitor of the cleavage at pairs of basic amino acids by IRCM-SP1. The substrates tested included pituitary ACTH and adrenal medulla pro-enkephalin-derived peptides such as the 8.6 kDa synenkephalin-containing precursor and peptide B. Chromogranin A is itself selectively processed by IRCM-SP1, and ACTH was shown to compete for such cleavage. These data suggest that chromogranins as a class of acidic proteins could participate in the tissue-specific processing of pro-hormones.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号